scispace - formally typeset
S

Simona Degli Esposti

Researcher at UCL Institute of Ophthalmology

Publications -  50
Citations -  1827

Simona Degli Esposti is an academic researcher from UCL Institute of Ophthalmology. The author has contributed to research in topics: Medicine & Visual acuity. The author has an hindex of 13, co-authored 43 publications receiving 962 citations. Previous affiliations of Simona Degli Esposti include University College London & Ludwig Maximilian University of Munich.

Papers
More filters
Journal ArticleDOI

Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study.

TL;DR: Single-agent belantamab mafodotin shows anti-myeloma activity with a manageable safety profile in patients with relapsed or refractory multiple myeloma.
Journal ArticleDOI

A 2-Year Prospective Randomized Controlled Trial of Intravitreal Bevacizumab or Laser Therapy (BOLT) in the Management of Diabetic Macular Edema: 24-Month Data: Report 3

TL;DR: This study provides evidence supporting longer-term use of intravitreous bevacizumab for persistent center-involving CSME and difference in ETDRS best-corrected visual acuity (BCVA) between arms.
Journal ArticleDOI

Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

Charles C. Wykoff, +385 more
- 01 Jan 2022 - 
TL;DR: Robust vision gains and anatomical improvements with faricimab were achieved with adjustable dosing up to every 16 weeks, demonstrating the potential for faricIMab to extend the durability of treatment for patients with diabetic macular oedema.